Clinical effectiveness of platelets in additive solution treated with two commercial pathogen‐reduction technologies

BACKGROUND Two noninferiority, randomized, controlled trials were conducted in parallel comparing the safety and efficacy of platelets treated with Intercept or Mirasol pathogen‐reduction technologies versus standard platelets. STUDY DESIGN AND METHODS The primary endpoint was the percentage of hema...

全面介绍

Saved in:
书目详细资料
Main Authors: Paolo Rebulla, Stefania Vaglio, Francesco Beccaria, Maurizio Bonfichi, Angelo Michele Carella, Federico Chiurazzi, Serelina Coluzzi, Agostino Cortelezzi, Giorgio Gandini, G. Girelli, Graf M, Paola Isernia, Giuseppe Marano, Maurizio Marconi, Rachele Montemezzi, Barbara Olivero, Marianna Rinaldi, L. Salvaneschi, N. Scarpato, Paolo Strada, Silvano Milani, Giuliano Grazzini
格式: Artigo
语言:英语
出版: 2017
在线阅读:https://doi.org/10.1111/trf.14042
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/trf.14042
标签: 添加标签
没有标签, 成为第一个标记此记录!